HAEMOSTATIX LIMITED - Profile & Financials

Accounts Submitted 3 Oct 2025

Confirmation Statement Submitted 28 Mar 2025

Net assets £-513.61K £105.38K 2023 year on year

Total assets £16.09K £2.82K 2023 year on year

Total Liabilities £529.70K £108.20K 2023 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

1 Occam Court Occam Road Surrey Research Park Guildford GU2 7HJ England

Office ()

Nottingham, Nottingham, United Kingdom, Europe

Office (Biocity Nottingham, UK)

null

Telephone

0011 591 24512

dpo@ergomedplc.com

Website

haemostatix.com

Credit Report

Discover HAEMOSTATIX LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

£1.45k

Increased by £56.00 (+4%)

Net Assets

-£513.61k

Decreased by £105.38k (-26%)

Total Liabilities

£529.70k

Increased by £108.20k (+26%)

Turnover

N/A

Employees

N/A

Debt Ratio

3291%

Increased by 116 (+4%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End	2022 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

1 active 19 resigned

Show resigned officers

						Status
Miroslav Reljanovic	Director	Croatian	Croatia	67	24 May 2016	Active

Shareholders

Shareholders (1)


Ergomed Group Limited	100.0%	270	Ordinary Shares	28 Mar 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Ergomed Group Limited

United Kingdom

Active

Notified 26 May 2016

Nature of Control

Ownership Of Shares 75 To 100 Percent

See All Controllers

Group Structure

ERGOMED GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

EDEN ACQUISITIONCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

EDEN HOLDCO 3 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

EDEN HOLDCO 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

EDEN HOLDCO 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

EDEN TOPCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

EIGHTPLATFORM V LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

PERMIRA VIII INVESTMENT PLATFORM LIMITED united kingdom

HAEMOSTATIX LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
3 Oct 2025	Accounts	Annual accounts made up to 2024-12-31	View(22 pages)
12 Aug 2025	Officers	Termination of Jonathan Andrew Curtain as director on 2025-07-31	View(1 page)
28 Mar 2025	Confirmation Statement	Confirmation statement made on 2025-03-14 with updates	View(4 pages)
7 Oct 2024	Accounts	Annual accounts made up to 2023-12-31	View(22 pages)
20 Mar 2024	Confirmation Statement	Confirmation statement made on 2024-03-14 with no updates	View(3 pages)